Correlation Between Novavax and Tonix Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Novavax and Tonix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novavax and Tonix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novavax and Tonix Pharmaceuticals Holding, you can compare the effects of market volatilities on Novavax and Tonix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novavax with a short position of Tonix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novavax and Tonix Pharmaceuticals.
Diversification Opportunities for Novavax and Tonix Pharmaceuticals
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Novavax and Tonix is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Novavax and Tonix Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tonix Pharmaceuticals and Novavax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novavax are associated (or correlated) with Tonix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tonix Pharmaceuticals has no effect on the direction of Novavax i.e., Novavax and Tonix Pharmaceuticals go up and down completely randomly.
Pair Corralation between Novavax and Tonix Pharmaceuticals
Given the investment horizon of 90 days Novavax is expected to under-perform the Tonix Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Novavax is 1.28 times less risky than Tonix Pharmaceuticals. The stock trades about -0.12 of its potential returns per unit of risk. The Tonix Pharmaceuticals Holding is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 15.00 in Tonix Pharmaceuticals Holding on August 31, 2024 and sell it today you would earn a total of 4.00 from holding Tonix Pharmaceuticals Holding or generate 26.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 97.78% |
| Values | Daily Returns |
Novavax vs. Tonix Pharmaceuticals Holding
Performance |
| Timeline |
| Novavax |
| Tonix Pharmaceuticals |
Novavax and Tonix Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novavax and Tonix Pharmaceuticals
The main advantage of trading using opposite Novavax and Tonix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novavax position performs unexpectedly, Tonix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tonix Pharmaceuticals will offset losses from the drop in Tonix Pharmaceuticals' long position.The idea behind Novavax and Tonix Pharmaceuticals Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Tonix Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Tonix Pharmaceuticals vs. Palisade Bio | Tonix Pharmaceuticals vs. Ibio Inc | Tonix Pharmaceuticals vs. Jaguar Animal Health |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |